Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine and Rituximab in Untreated MALT Lymphoma
NCT01015248Phase 2Completed
- Sponsor
- GELTAMO
- Start
- May 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine, rituximab in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, sponsored by GELTAMO. Started May 2009; status: completed.
02
Drugs
bendamustinerituximab
03
Conditions
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
Beyond the preview
Go deeper on NCT01015248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015248.